Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible

Anti-Bacterial Agents / pharmacology Australia Burkholderia pseudomallei Cephalosporins / pharmacology Drug Resistance, Multiple, Bacterial Microbial Sensitivity Tests Queensland Siderophores / pharmacology Cefiderocol
AMR Burkholderia pseudomallei MIC antimicrobial resistance cefiderocol melioidosis minimum inhibitory concentration

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
20 01 2021
Historique:
received: 09 04 2020
accepted: 22 10 2020
pubmed: 11 11 2020
medline: 22 6 2021
entrez: 10 11 2020
Statut: epublish

Résumé

Cefiderocol is a cephalosporin designed to treat multidrug-resistant Gram-negative infections. By forming a chelated complex with ferric iron, cefiderocol is transported into the periplasmic space via bacterial iron transport systems and primarily binds to penicillin-binding protein 3 (PBP3) to inhibit peptidoglycan synthesis. This mode of action results in cefiderocol having greater

Identifiants

DOI: 10.1128/AAC.00685-20 PMID: 33168603 PMC: PMC7848980
pubmed: 33168603
pii: AAC.00685-20
doi: 10.1128/AAC.00685-20
pmc: PMC7848980
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cephalosporins 0
Siderophores 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Crown copyright 2021.

Références

Clin Microbiol Infect. 2006 Jun;12(6):501-3
pubmed: 16700696
Drug Resist Updat. 2016 Sep;28:82-90
pubmed: 27620956
Int J Antimicrob Agents. 2014 Aug;44(2):160-2
pubmed: 24924662
Int J Antimicrob Agents. 2001 Feb;17(2):109-13
pubmed: 11165114
Int J Antimicrob Agents. 2019 Apr;53(4):456-466
pubmed: 30471402
Future Microbiol. 2012 Dec;7(12):1389-99
pubmed: 23231488
Antimicrob Agents Chemother. 2011 Nov;55(11):5388-91
pubmed: 21876049
Appl Environ Microbiol. 2014 Jun;80(11):3463-8
pubmed: 24657869
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7396-7401
pubmed: 27736756
J Antimicrob Chemother. 2017 Jun 1;72(6):1704-1708
pubmed: 28369471
Diagn Microbiol Infect Dis. 2017 Jun;88(2):198-200
pubmed: 28410852
J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78
pubmed: 29514274
Clin Microbiol Rev. 2005 Apr;18(2):383-416
pubmed: 15831829
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2319-2327
pubmed: 28748397
Drugs. 2019 Feb;79(3):271-289
pubmed: 30712199
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29061741
Front Cell Infect Microbiol. 2018 Jun 25;8:210
pubmed: 30013953
Lancet Infect Dis. 2018 Dec;18(12):1319-1328
pubmed: 30509675
Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S1-4
pubmed: 19121666
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311072
N Engl J Med. 2012 Sep 13;367(11):1035-44
pubmed: 22970946
Trop Med Infect Dis. 2018 Mar 01;3(1):
pubmed: 30274424
Expert Rev Anti Infect Ther. 2019 Dec;17(12):957-967
pubmed: 30626237
Nat Microbiol. 2016 Jan 11;1:15008
pubmed: 27571754
J Clin Microbiol. 2016 Dec;54(12):2866-2873
pubmed: 27654336
Clin Microbiol Rev. 2020 Mar 11;33(2):
pubmed: 32161067

Auteurs

Delaney Burnard (D)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.

Gemma Robertson (G)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Pathology Queensland, Queensland Health, Herston, Queensland, Australia.
Forensic and Scientific Services, Queensland Health, Coopers Plains, Queensland, Australia.

Andrew Henderson (A)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Princess Alexandra Hospital, Queensland Health, Woolloongabba, Queensland, Australia.

Caitlin Falconer (C)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.

Michelle J Bauer (MJ)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.

Kyra Cottrell (K)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.

Ian Gassiep (I)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Department of Infectious Diseases, Mater Hospital, Brisbane, Queensland, Australia.

Robert Norton (R)

Townsville Hospital and Health Service, Townsville, Queensland, Australia.
Faculty of Medicine, University of Queensland, Herston, Queensland, Australia.

David L Paterson (DL)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Royal Brisbane and Women's Hospital, Queensland Health, Herston, Queensland, Australia.
ORCID: 0000-0003-2079-4437

Patrick N A Harris (PNA)

University of Queensland Centre for Clinical Research, Herston, Queensland, Australia p.harris@uq.edu.au.
Pathology Queensland, Queensland Health, Herston, Queensland, Australia.
ORCID: 0000-0002-2895-0345

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia pseudomallei › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Queensland › Burkholderia pseudomallei Clinical Isolates...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Agents séquestrants › Chélateurs › Agents chélateurs du fer › Sidérophores › Burkholderia pseudomallei Clinical Isolates...